SWE
Toggle navigation
English
Svenska
About Us
The Company
Board & Management
Scientific Advisory Board
Scientific Publications
Events & Mediawatch
Careers
Contact Us
Expanded Access Policy
Type 1 Diabetes
Pipeline
Manufacturing
Clinical Trials
Investors
Investor Relations
CEO Comments
Corporate Governance
Press Releases
Financial Reports
Financial Calendar
Home
»
Events & Mediawatch
»
Nasdaq Signature Series: interview with Diamyd CEO and President Elisabeth Lindner
December 9, 2008
USA
Nasdaq Signature Series: interview with Diamyd CEO and President Elisabeth Lindner
Diamyd CEO and President Mrs Elisabeth Lindner was interviewed in New York at Nasdaq Market Site, Wednesday morning December 9th, 2008.
See the whole interview here
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.
More articles
Follow Us
Share This
select
Facebook
Twitter
LinkedIn
Google Plus
Pinterest
Tumblr
StumbleUpon
Blogger
MySpace
Digg
Reddit
Email
Press Releases
June 11, 2026
Diamyd Medical receives Notice of Allowance for Key Precision Medicine Patent
Financial Reports
March 25, 2026
Quarterly Report 2 25/26
Order GAD for preclinical research
ORDER
©
Privacy Policy
|
Cookie Policy
|
Expanded Access Policy
Share This Page
select
Facebook
Twitter
LinkedIn
Google Plus
Pinterest
Tumblr
StumbleUpon
Blogger
MySpace
Digg
Reddit
Email
GAD PRODUCTS
Order GAD for preclinical research